Detalhe da pesquisa
1.
Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting.
Int J Clin Oncol
; 26(6): 1057-1064, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715058
2.
Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients.
Cancer Immunol Immunother
; 68(10): 1585-1596, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515670
3.
[Aggresive angiomyxoma after renal transplantation]. / Angiomixoma agresivo postrasplante renal.
Medicina (B Aires)
; 78(6): 440-442, 2018.
Artigo
em Espanhol
| MEDLINE | ID: mdl-30504112
4.
First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study.
World J Clin Oncol
; 13(2): 147-158, 2022 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316930
5.
Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
World J Clin Oncol
; 12(1): 1-5, 2021 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33552934
6.
Angiomixoma agresivo postrasplante renal / Aggresive angiomyxoma after renal transplantation
Medicina (B.Aires)
; 78(6): 440-442, Dec. 2018. ilus
Artigo
em Espanhol
| LILACS | ID: biblio-976143